NCT04005729View on ClinicalTrials.gov

Cangrelor in Comatose Survivors of OHCA Undergoing Primary PCI

PHASE4CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

July 1, 2019

Primary Completion Date

November 27, 2021

Study Completion Date

November 27, 2021

Conditions
Out-Of-Hospital Cardiac ArrestAcute Coronary Syndrome
Interventions
DRUG

Cangrelor 50 MG

30 mcg/kg bolus, then 4h infusion 4 mcg/kg/min

Trial Locations (1)

1000

University Medical Centre Ljubljana, Ljubljana

All Listed Sponsors
collaborator

Chiesi Slovenija, d.o.o.

INDUSTRY

lead

University Medical Centre Ljubljana

OTHER

NCT04005729 - Cangrelor in Comatose Survivors of OHCA Undergoing Primary PCI | Biotech Hunter | Biotech Hunter